Ye Chen
MicroRNA-based integrated diagnosis and therapy for GBM: current status and advances
Glioblastoma (GBM) is the most common and aggressive type of central nervous system cancer, characterized by high rates of recurrence and mortality. As the highest-grade glioma, patient prognosis remains poor despite multimodal interventions including …